12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Company News  |  Other News

Agalimmune cancer news

Loxbridge Research LLP and Animatrix Capital LLP founded newco Agalimmune to develop immunotherapies to treat cancer, with a focus on solid tumors. Agalimmune...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >